Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
International Journal for Parasitology|January 9, 1998
Genetic structure of Trypanosoma cruzi in Central America and its comparison with South American strainsH Higo, T Yanagi, V Matta, et al.The Journal of Antibiotics|August 2, 2001
RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptorS Toki, T Agatsuma, K Ochiai, et al.Journal of Helminthology|November 25, 2003
The origin of the triploid in Paragonimus westermani on the basis of variable regions in the mitochondrial DNAT Agatsuma, M Iwagami, Y Sato, et al.Cancer Research|June 26, 1999
KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling moleculesS Soga, L M Neckers, T W Schulte, et al.Journal of Helminthology|May 23, 2002
Affinities between Asian non-human Schistosoma species, the S. indicum group, and the African human schistosomesT Agatsuma, M Iwagami, C X Liu, et al.Journal of Comparative Pathology|February 19, 2010
Meningoencephalitis associated with Sarcocystis spp. in a free-living Japanese raccoon dog (Nyctereutes procyonoides viverrinus)M Kubo, T Kawachi, M Murakami, et al.Bioorganic & Medicinal Chemistry|January 30, 1999
Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activityM Koizumi, R Koga, H Hotoda, et al.International Journal for Parasitology|March 25, 2000
Chromosomal differentiation of the Schistosoma japonicum complexH Hirai, T Taguchi, Y Saitoh, et al.Bioorganic & Medicinal Chemistry|February 12, 1998
Biologically active oligodeoxyribonucleotides--IX. Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3'- and 5'-end-modificationM Koizumi, R Koga, H Hotoda, et al.Journal of Medicinal Chemistry|September 11, 1998
Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structureH Hotoda, M Koizumi, R Koga, et al.Pageof 8